Search

Author/Creator Kondrashova, O.

1. 2773 ALLOCATE: sorting ovarian cancer patients into treatment categories based on genetic characteristics of their tumours. (September 2015)

Authors:
Kondrashova, O.; Lunke, S.; Mileshkin, L.; Alsop, K.; Scott, C.; Hamilton, A.; Ananda, S.; Quinn, M.; Bowtell, D.; McNally, O.; Cowie, T.; Wakefield, M.; Hsu, A.; Taylor, G.; Waring, P.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S555
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Secondary mutations in RAD51C and RAD51D are associated with acquired resistance to the PARP inhibitor rucaparib in patients with high-grade ovarian cancer. (December 2016)

Authors:
Lin, K.; Tinker, A.V.; Kondrashova, O.; Ho, G.; Wakefield, M.; Coleman, R.L.; O'Malley, D.M.; Floquet, A.; Sun, J.; Maloney, L.; Giordano, H.; Harding, T.; Raponi, M.; McNeish, I.A.; Swisher, E.; Scott, C.L.
Journal:
European journal of cancer
Issue:
Volume 69(2016)supplement 1
Page Start:
S13
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search